GO:0004993 G protein-coupled serotonin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004993 describes the molecular function of binding serotonin (5-hydroxytryptamine) and transmitting the signal across the membrane by activating an associated G-protein.
• Serotonin GPCRs comprise 13 distinct receptors (5-HT1 to 5-HT7 families) that couple to different G-alpha proteins, including Gs, Gi/o, and Gq/11.
• Constitutive (ligand-independent) activity is a well-documented feature of several serotonin receptors, influencing basal signaling and drug efficacy.
• Alternative splicing and RNA editing generate receptor isoforms with altered signaling properties, as shown for the 5-HT2C receptor.
• Serotonin GPCRs are validated drug targets in psychiatry, migraine, nausea, and emerging psychedelic therapeutics, with polypharmacology driving new drug discovery.
• CRISPR-based knockout, point mutation, and knock-in models enable precise dissection of receptor-specific signaling in native cellular contexts.
Description
G protein-coupled serotonin receptor activity (GO:0004993) is a molecular function defined as combining with the biogenic amine serotonin and transmitting the signal across the membrane by activating an associated G-protein. Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter and hormone found in vertebrates and invertebrates, and its receptors are among the most extensively studied GPCR subfamilies. This activity is central to diverse physiological processes, including mood regulation, appetite, sleep, vascular tone, and gastrointestinal motility. Researchers studying neuropsychopharmacology, GPCR structural biology, and drug discovery rely on this GO term to annotate gene products and interpret functional genomics data. The serotonin receptor family includes 13 members in humans, each with distinct coupling preferences and expression patterns, making GO:0004993 a critical node for understanding both normal physiology and disease. Recent advances in structural biology and single-molecule pharmacology have revealed dynamic mechanisms of receptor activation and G-protein coupling, underscoring the importance of precise functional annotation. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0004993, its mechanisms, associated genes, disease relevance, and experimental models.
G protein-coupled serotonin receptor activity At A Glance
| GO ID | GO:0004993 |
|---|---|
| GO term | G protein-coupled serotonin receptor activity |
| Ontology | molecular_function |
| Synonym | 5-HT receptor; 5-hydroxytryptamine receptor; G protein coupled serotonin receptor activity; G-protein coupled serotonin receptor activity |
| Major function | Binding serotonin and activating an associated G-protein to transmit signals across the membrane |
| Receptor families | 5-HT1 (Gi/o), 5-HT2 (Gq/11), 5-HT4/6/7 (Gs), 5-HT5 (Gi/o) |
| Constitutive activity | Several serotonin receptors exhibit ligand-independent G-protein activation |
| Splice variants | Alternative splicing and RNA editing generate functionally distinct isoforms, e.g., 5-HT2C |
| Endogenous ligand | Serotonin (5-hydroxytryptamine), a neurotransmitter and hormone in vertebrates and invertebrates |
What Is GO:0004993?
GO:0004993, G protein-coupled serotonin receptor activity, is a molecular function that entails the selective binding of serotonin (5-hydroxytryptamine) to a G protein-coupled receptor, which then undergoes conformational changes to activate an associated heterotrimeric G-protein, thereby transmitting the signal across the cell membrane. This activity is distinct from other serotonin receptor activities such as ligand-gated ion channel activity. The term encompasses all serotonin receptors that signal through G-proteins, including the 5-HT1, 5-HT2, 5-HT4, 5-HT5, 5-HT6, and 5-HT7 families. The definition emphasizes both ligand binding and G-protein activation as essential components of the function.
Why Is G protein-coupled serotonin receptor activity Important in Cell Biology?
GO:0004993 is critically important because serotonin GPCRs mediate a vast array of physiological and behavioral processes, and their dysfunction is implicated in numerous human diseases, including depression, anxiety, schizophrenia, migraine, obesity, and gastrointestinal disorders. These receptors are the targets of many FDA-approved drugs, such as triptans, atypical antipsychotics, and antiemetics, as well as emerging psychedelic therapeutics. Understanding the molecular details of serotonin receptor activity is essential for rational drug design, especially given the prevalence of polypharmacology among serotonergic ligands. Moreover, constitutive activity and signaling bias at these receptors can significantly impact drug efficacy and side effects. The study of GO:0004993 also extends to invertebrates, where serotonin signaling controls parasite movement, highlighting its evolutionary conservation and potential as an antiparasitic target.
• Serotonin GPCRs regulate mood, anxiety, and cognition, making them central to psychiatric disorders.
• They control vascular tone and platelet aggregation, with implications for cardiovascular disease.
• They modulate gastrointestinal motility and secretion, relevant to irritable bowel syndrome.
• They are targets for migraine therapies (triptans) and antiemetics (setrons).
• Constitutive activity of serotonin receptors influences basal signaling and drug responses.
• Signaling bias at 5-HT1A affects downstream pathways and potential therapeutic outcomes.
• Alternative splicing of 5-HT2C produces isoforms with altered function, linked to neuropsychiatric phenotypes.
• Serotonin receptors are involved in feeding behavior and energy balance, relevant to obesity.
• In parasites like Schistosoma mansoni, serotonin GPCRs control movement and represent drug targets.
• Psychedelics exert therapeutic effects through serotonin GPCRs, driving new drug discovery.
What Happens During G protein-coupled serotonin receptor activity?
Serotonin binding and receptor activation
In simple terms: Serotonin binds to the receptor like a key in a lock, causing the receptor to change shape.
The process begins when serotonin (5-hydroxytryptamine) binds to the orthosteric pocket of a serotonin GPCR, typically within the transmembrane helical bundle. This binding induces conformational changes, particularly in transmembrane helix 6, that propagate to the intracellular side of the receptor. The receptor transitions from an inactive to an active state, creating a binding site for the G-protein. Different serotonin receptors exhibit varying affinities for serotonin, and some possess constitutive activity even in the absence of ligand.
G-protein coupling and activation
In simple terms: The activated receptor turns on a G-protein, which then relays the signal inside the cell.
Upon activation, the receptor acts as a guanine nucleotide exchange factor (GEF) for the associated heterotrimeric G-protein. The G-alpha subunit exchanges GDP for GTP, dissociating from the G-beta-gamma dimer. Different serotonin receptors couple preferentially to distinct G-alpha subtypes: 5-HT1 and 5-HT5 couple to Gi/o, inhibiting adenylyl cyclase; 5-HT2 couples to Gq/11, activating phospholipase C; and 5-HT4, 5-HT6, and 5-HT7 couple to Gs, stimulating adenylyl cyclase. Single-molecule studies have shown that the 5-HT7 receptor slows down Gs protein dynamics during coupling.
Downstream signaling and second messengers
In simple terms: The G-protein triggers a cascade of signals inside the cell, leading to various cellular responses.
Activated G-alpha subunits modulate effector enzymes such as adenylyl cyclase and phospholipase C, altering levels of second messengers like cAMP, IP3, and diacylglycerol. These second messengers activate protein kinases and ion channels, leading to diverse cellular responses including changes in gene expression, neuronal excitability, and neurotransmitter release. Signaling bias, where a ligand preferentially activates one pathway over another, has been demonstrated at the 5-HT1A receptor, affecting downstream responses.
Receptor desensitization and internalization
In simple terms: After signaling, the receptor is turned off and pulled inside the cell to prevent overstimulation.
Following prolonged agonist exposure, serotonin receptors undergo desensitization via phosphorylation by G-protein-coupled receptor kinases (GRKs) and recruitment of beta-arrestins. Beta-arrestin binding uncouples the receptor from G-proteins and promotes internalization through clathrin-coated pits. This process regulates the duration and intensity of serotonin signaling and is implicated in drug tolerance and withdrawal. Constitutive activity can also influence basal desensitization states.
Key Genes Involved in GO:0004993 G protein-coupled serotonin receptor activity
The following genes encode the major serotonin receptors and associated signaling proteins that mediate GO:0004993.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HTR1A | 5-HT1A receptor, couples to Gi/o, inhibits cAMP | Target for anxiolytics and antidepressants; signaling bias studied |
| HTR1B | 5-HT1B receptor, Gi/o-coupled, modulates neurotransmitter release | Implicated in migraine and aggression |
| HTR1D | 5-HT1D receptor, Gi/o-coupled | Target of triptans for migraine |
| HTR1E | 5-HT1E receptor, Gi/o-coupled | Less studied; potential role in cognition |
| HTR1F | 5-HT1F receptor, Gi/o-coupled | Target for migraine therapy |
| HTR2A | 5-HT2A receptor, Gq/11-coupled, activates PLC | Primary target of psychedelics and atypical antipsychotics |
| HTR2B | 5-HT2B receptor, Gq/11-coupled | Associated with cardiac valvulopathy and pulmonary hypertension |
| HTR2C | 5-HT2C receptor, Gq/11-coupled, RNA-edited and spliced | Regulates appetite and mood; splice variants affect function |
| HTR3A | 5-HT3A receptor, ligand-gated ion channel (not GPCR) | Distinct from GO:0004993; target of antiemetics |
| HTR4 | 5-HT4 receptor, Gs-coupled, stimulates cAMP | Modulates gastrointestinal motility and memory |
| HTR5A | 5-HT5A receptor, Gi/o-coupled | Potential role in circadian rhythms and psychiatric disorders |
| HTR6 | 5-HT6 receptor, Gs-coupled | Target for cognitive enhancement in Alzheimer's disease |
| HTR7 | 5-HT7 receptor, Gs-coupled | Regulates circadian rhythm and mood; single-molecule dynamics studied |
| GNAS | Gs alpha subunit, couples to 5-HT4/6/7 | Mediates stimulatory cAMP signaling |
| GNAI1 | Gi alpha subunit, couples to 5-HT1/5 | Mediates inhibitory cAMP signaling |
| GNAQ | Gq alpha subunit, couples to 5-HT2 | Activates phospholipase C pathway |
| ARRB1 | Beta-arrestin 1, mediates desensitization | Regulates receptor internalization and biased signaling |
| ARRB2 | Beta-arrestin 2, mediates desensitization | Regulates receptor internalization and biased signaling |
How Is G protein-coupled serotonin receptor activity Regulated?
The activity of G protein-coupled serotonin receptors is regulated at multiple levels. Constitutive activity, or ligand-independent signaling, has been documented for several serotonin receptors and can be modulated by inverse agonists. Alternative splicing and RNA editing generate receptor isoforms with altered signaling properties; for example, the 5-HT2C receptor undergoes RNA editing that changes its G-protein coupling efficiency. Desensitization and internalization are controlled by GRK-mediated phosphorylation and beta-arrestin recruitment. Additionally, signaling bias can be influenced by the specific ligand and cellular context, as shown for the 5-HT1A receptor. Single-molecule studies have revealed that the 5-HT7 receptor slows Gs protein dynamics, providing a mechanism for temporal regulation of signaling.
G protein-coupled serotonin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HTR1A | Depression, anxiety | Knockout mouse, point mutation for signaling bias |
| HTR2A | Schizophrenia, psychedelic response | Knock-in mouse, overexpression in neurons |
| HTR2B | Cardiac valvulopathy, pulmonary hypertension | Knockout rat, conditional overexpression |
| HTR2C | Obesity, mood disorders | RNA editing knock-in, splice variant models |
| HTR7 | Circadian rhythm, depression | Knockout mouse, tagged knock-in for single-molecule imaging |
Psychiatric and neurological disorders
Serotonin GPCRs are heavily implicated in depression, anxiety, schizophrenia, and migraine. The 5-HT1A receptor is a key target for anxiolytics and antidepressants, and its signaling bias can affect therapeutic outcomes. The 5-HT2A receptor is the primary target of psychedelics and atypical antipsychotics, with polypharmacology contributing to their effects. Dysregulation of 5-HT2C splicing has been linked to neuropsychiatric phenotypes.
Cardiovascular and metabolic diseases
The 5-HT2B receptor is associated with drug-induced cardiac valvulopathy and pulmonary hypertension. Serotonin receptors also regulate vascular tone and platelet aggregation, impacting cardiovascular health. In metabolic disorders, 5-HT2C receptor signaling influences appetite and energy balance, making it a target for obesity drugs.
Gastrointestinal and parasitic diseases
5-HT4 receptor agonists are used to treat gastrointestinal motility disorders such as irritable bowel syndrome. In the parasite Schistosoma mansoni, a serotonin-activated GPCR controls parasite movement, highlighting potential for antiparasitic drug development.
From G protein-coupled serotonin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 5-HT1A affect anxiety-like behavior? | HTR1A knockout mouse |
| How does a point mutation in 5-HT2A alter psychedelic responses? | HTR2A point-mutation knock-in mouse |
| What is the effect of 5-HT2C RNA editing on appetite? | HTR2C editing-site knock-in mouse |
| Can we visualize 5-HT7 receptor dynamics in live cells? | Tagged knock-in of HTR7 with fluorescent protein |
| Does overexpression of 5-HT4 rescue memory deficits? | HTR4 overexpression in transgenic mouse |
| How does constitutive activity of 5-HT1A affect drug efficacy? | HTR1A constitutive-active knock-in |
How to Study the G protein-coupled serotonin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Receptor affinity and density | Drug screening and receptor characterization |
| cAMP assay | Gs/Gi-mediated cAMP changes | Functional assessment of 5-HT4/6/7 and 5-HT1 receptors |
| IP3 assay | Gq-mediated phospholipase C activation | Functional assessment of 5-HT2 receptors |
| Beta-arrestin recruitment | Receptor desensitization and biased signaling | Drug efficacy and side effect profiling |
| Single-molecule FRET | Real-time G-protein coupling dynamics | Mechanistic studies of receptor-G protein interactions |
| RNA-seq | Gene expression and splice variants | Tissue-specific expression and disease profiling |
| CRISPR knockout | Loss-of-function phenotypes | Target validation and pathway dissection |
| CRISPR knock-in | Precise mutation or tag introduction | Disease modeling and live-cell imaging |
Pharmacological and signaling assays
Ligand binding assays, cAMP accumulation, IP3 production, and beta-arrestin recruitment are standard methods to measure serotonin receptor activity. These assays can distinguish agonist, antagonist, and inverse agonist properties, and assess signaling bias.
Single-molecule and imaging techniques
Single-molecule fluorescence microscopy has been used to observe real-time G-protein coupling dynamics at the 5-HT7 receptor, revealing that the receptor slows Gs protein diffusion. Total internal reflection fluorescence (TIRF) and FRET-based sensors can monitor receptor conformational changes and downstream signaling in live cells.
Genetic and CRISPR-based models
CRISPR/Cas9 knockout, point mutation, and knock-in models allow precise manipulation of serotonin receptor genes in cell lines and animal models. These models are essential for dissecting receptor-specific functions and validating drug targets.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can quantify expression of serotonin receptors and signaling components across tissues and disease states. Alternative splicing and RNA editing of HTR2C can be detected by RNA-seq, providing insights into isoform-specific functions.
How CRISPR Can Be Used to Study GO:0004993 G protein-coupled serotonin receptor activity
Knockout
CRISPR knockout of serotonin receptor genes (e.g., HTR1A, HTR2A) in cell lines or animal models abolishes receptor expression, enabling loss-of-function studies to determine the receptor's role in signaling and behavior. Knockout models are valuable for validating drug targets and distinguishing receptor subtypes.
Point Mutation
Point mutations can be introduced into serotonin receptor genes to mimic naturally occurring variants or to disrupt specific signaling pathways. For example, point mutations in HTR1A can alter G-protein coupling efficiency and signaling bias, providing insights into structure-function relationships.
Knock-in
Knock-in of reporter tags (e.g., fluorescent proteins) or disease-associated mutations into endogenous serotonin receptor loci allows real-time visualization and functional analysis in native contexts. Knock-in models of HTR2C splice variants can elucidate isoform-specific roles in appetite regulation.
Overexpression
Overexpression of serotonin receptors in cell lines or transgenic animals can amplify signaling for biochemical assays or model receptor overactivity in disease. For example, overexpression of HTR7 has been used to study Gs coupling dynamics.
How EDITGENE Supports G protein-coupled serotonin receptor activity Research
Researchers studying G protein-coupled serotonin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, disease phenotypes, or drug responses. Precise genetic models are essential to move from correlation to causation. EDITGENE provides end-to-end CRISPR services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, tailored to serotonin receptor research.
Contact EDITGENE today to design your custom CRISPR model for G protein-coupled serotonin receptor activity research.
Frequently Asked Questions About G protein-coupled serotonin receptor activity
What is GO:0004993?
GO:0004993 is the Gene Ontology molecular function term for G protein-coupled serotonin receptor activity, defined as binding serotonin and activating an associated G-protein to transmit signals across the membrane.
What genes are involved in G protein-coupled serotonin receptor activity?
The main genes include HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, and HTR7, which encode the 13 serotonin GPCRs.
How do serotonin receptors signal?
They bind serotonin, change conformation, and activate heterotrimeric G-proteins (Gs, Gi/o, or Gq/11), which then modulate second messengers like cAMP and IP3.
What diseases are linked to serotonin GPCRs?
They are implicated in depression, anxiety, schizophrenia, migraine, obesity, cardiovascular disease, and gastrointestinal disorders.
What is constitutive activity of serotonin receptors?
Constitutive activity is ligand-independent G-protein activation observed in several serotonin receptors, which can affect basal signaling and drug efficacy.
How is 5-HT2C receptor activity regulated?
It is regulated by alternative splicing and RNA editing, which produce isoforms with altered signaling properties.
Can CRISPR be used to study serotonin receptors?
Yes, CRISPR knockout, point mutation, and knock-in models enable precise functional studies of serotonin receptors in cells and animals.
What is signaling bias at serotonin receptors?
Signaling bias is the preferential activation of one downstream pathway over another by a ligand, as demonstrated at the 5-HT1A receptor.
Are serotonin receptors involved in parasite biology?
Yes, a serotonin-activated GPCR controls movement in Schistosoma mansoni, highlighting potential antiparasitic targets.
How do psychedelics interact with serotonin receptors?
Psychedelics primarily target the 5-HT2A receptor and exhibit polypharmacology across multiple serotonin receptors, contributing to their therapeutic effects.
Conclusion
GO:0004993, G protein-coupled serotonin receptor activity, is a fundamental molecular function that underlies diverse physiological processes and is implicated in numerous diseases. The 13 serotonin GPCRs couple to distinct G-proteins and exhibit complex regulation, including constitutive activity, splicing, and signaling bias. Advances in structural biology, single-molecule imaging, and CRISPR-based models continue to unravel the mechanistic details of these receptors. Understanding this GO term is essential for drug discovery, especially for psychiatric, cardiovascular, and metabolic disorders. EDITGENE provides comprehensive CRISPR services to support functional studies of serotonin receptors, from knockout to knock-in and library screening.
References
- 1. Jain MK et al.. 2025. The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.. Neuron 113(19):3129-3142.e9 PMID: 40683247
- 2. Teitler M et al.. 2002. Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors.. Curr Top Med Chem 2(6):529-38 PMID: 12052192
- 3. Lanfumey L et al.. 2004. 5-HT1 receptors.. Curr Drug Targets CNS Neurol Disord 3(1):1-10 PMID: 14965240
- 4. Alabdali R et al.. 2023. Gα Protein Signaling Bias at Serotonin 1A Receptor.. Mol Pharmacol 104(5):230-238 PMID: 37567783
- 5. Petelák A et al.. 2023. Serotonin 5-HT(7) receptor slows down the G(s) protein: a single molecule perspective.. Mol Biol Cell 34(9):br14 PMID: 37342875
- 6. McCorvy JD et al.. 2015. Structure and function of serotonin G protein-coupled receptors.. Pharmacol Ther 150:129-42 PMID: 25601315
- 7. Patocka N et al.. 2014. Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement.. PLoS Pathog 10(1):e1003878 PMID: 24453972
- 8. Stamm S et al.. 2017. The activity of the serotonin receptor 2C is regulated by alternative splicing.. Hum Genet 136(9):1079-1091 PMID: 28664341
